Sub Banner Image

Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?

Equities

Zacks Investment Research

·

June 16, 2025

·

Barchart

Johnson & Johnson JNJ has one of the most diverse revenue streams in the industry within the pharmaceutical division called Innovative Medicine. Under this segment, J&J markets several multi-million-dollar drugs covering a broad range of areas such as neuroscience, cardiovascular and metabolism, immunology, oncology, pulmonary hypertension and infectious diseases.J&J’s Innovative...

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.